- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti Viral
- Anti-Depressants
- Anti-Inflammatory
- Antibacterial
- Antiparasitic
- Antibiotics
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Veterinary Medicines
- Quit Smoking
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
Generic Arimidex ( Anastrozole )
Arimidex (anastrozole) is a non‑steroidal aromatase inhibitor indicated for the adjuvant treatment of postmenopausal women with hormone receptor‑positive early breast cancer, for the first‑line treatment of postmenopausal women with hormone receptor‑positive or hormone receptor‑unknown locally advanced or metastatic breast cancer, and for advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Anastrozole works by selectively inhibiting the aromatase enzyme, which is responsible for converting androgens to estrogens in peripheral tissues. In postmenopausal women, this leads to a marked suppression of circulating estradiol levels, thereby reducing estrogen‑driven tumour growth. Arimidex is not effective in premenopausal women and should not be used in this population.
Usual adult dose: The recommended dose is 1 mg taken orally once daily, with or without food. Treatment is continued until disease progression or unacceptable toxicity in the metastatic setting; in the adjuvant setting, the optimal duration is generally 5 years, or as determined by the treating oncologist. No dose adjustment is required for elderly patients or for those with mild to moderate renal or hepatic impairment. In patients with severe hepatic impairment or severe renal impairment, use should be undertaken with caution. If a dose is missed, the patient should take the next dose at the usual time; two doses must not be taken on the same day. Arimidex should be swallowed whole with water.
Dosage form: Film‑coated tablets: 1 mg (white, round, biconvex, debossed with “A” on one side and “1” on the other). Available in blister packs or bottles of 30 tablets.
Onset of action: Estradiol levels are reduced by approximately 70% within 24 hours and by approximately 80% after 14 days of daily dosing. Steady‑state plasma concentrations of anastrozole are reached within about 7 days. Clinical benefit in breast cancer, such as tumour regression or delay in disease progression, is typically assessed after several weeks to months of continuous therapy.
Duration of action: The elimination half‑life of anastrozole is approximately 50 hours, supporting once‑daily dosing. Estrogen suppression persists throughout the dosing interval and is maintained with continuous daily therapy. After discontinuation, estradiol levels gradually return to baseline over several days.
Alcohol recommendation: No direct interaction between anastrozole and alcohol has been clearly established. However, excessive alcohol consumption may increase the risk of hot flashes, contribute to bone loss, and impair overall treatment tolerance. Patients should limit alcohol intake and discuss any concerns with their oncologist.
Most common side effects: Hot flashes, asthenia (weakness), arthralgia (joint pain), arthritis, bone pain, headache, nausea, and peripheral edema. Musculoskeletal symptoms are frequent and may require symptomatic management. Anastrozole reduces circulating estrogen and therefore causes loss of bone mineral density; osteoporosis and increased fracture risk are significant long‑term concerns. Bone density should be assessed at baseline and periodically, and calcium and vitamin D supplementation as well as bisphosphonates may be considered. Other effects include mood changes, depression, hypertension, and hypercholesterolemia. In women with pre‑existing ischemic heart disease, anastrozole has been associated with a slightly increased risk of cardiovascular events. Because Arimidex suppresses estrogen to near undetectable levels, it is not effective in premenopausal women; a reliable method of contraception is required in women of childbearing potential if used off‑label. Arimidex is available only by prescription and must be prescribed and monitored by a healthcare professional experienced in oncology.
Would you like to try Arimidex (Anastrozole) without a prescription?
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
